The STDs Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global STDs Diagnosis market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Point-Of-Care (POC) Testing accounting for % of the STDs Diagnosis global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Gonorrhea Testing segment is altered to a % CAGR between 2022 and 2028.
Global key companies of STDs Diagnosis include Becton, Dickinson, Roche Diagnostics, Biomerieux, and Gen-Probe, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
STDs Diagnosis market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Gonorrhea Testing
Human Papilloma Virus (HPV) Testing
Chlamydia Testing
Chancroid Testing
Other
Market segment by Application, can be divided into
Point-Of-Care (POC) Testing
Laboratory Testing
Market segment by players, this report covers
Becton
Dickinson
Roche Diagnostics
Biomerieux
Gen-Probe
Beckman Coulter
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe STDs Diagnosis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of STDs Diagnosis, with revenue, gross margin and global market share of STDs Diagnosis from 2019 to 2022.
Chapter 3, the STDs Diagnosis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and STDs Diagnosis market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe STDs Diagnosis research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of STDs Diagnosis
1.2 Classification of STDs Diagnosis by Type
1.2.1 Overview: Global STDs Diagnosis Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global STDs Diagnosis Revenue Market Share by Type in 2021
1.2.3 Gonorrhea Testing
1.2.4 Human Papilloma Virus (HPV) Testing
1.2.5 Chlamydia Testing
1.2.6 Chancroid Testing
1.2.7 Other
1.3 Global STDs Diagnosis Market by Application
1.3.1 Overview: Global STDs Diagnosis Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Point-Of-Care (POC) Testing
1.3.3 Laboratory Testing
1.4 Global STDs Diagnosis Market Size & Forecast
1.5 Global STDs Diagnosis Market Size and Forecast by Region
1.5.1 Global STDs Diagnosis Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global STDs Diagnosis Market Size by Region, (2017-2022)
1.5.3 North America STDs Diagnosis Market Size and Prospect (2017-2028)
1.5.4 Europe STDs Diagnosis Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific STDs Diagnosis Market Size and Prospect (2017-2028)
1.5.6 South America STDs Diagnosis Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa STDs Diagnosis Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 STDs Diagnosis Market Drivers
1.6.2 STDs Diagnosis Market Restraints
1.6.3 STDs Diagnosis Trends Analysis
2 Company Profiles
2.1 Becton
2.1.1 Becton Details
2.1.2 Becton Major Business
2.1.3 Becton STDs Diagnosis Product and Solutions
2.1.4 Becton STDs Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Becton Recent Developments and Future Plans
2.2 Dickinson
2.2.1 Dickinson Details
2.2.2 Dickinson Major Business
2.2.3 Dickinson STDs Diagnosis Product and Solutions
2.2.4 Dickinson STDs Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Dickinson Recent Developments and Future Plans
2.3 Roche Diagnostics
2.3.1 Roche Diagnostics Details
2.3.2 Roche Diagnostics Major Business
2.3.3 Roche Diagnostics STDs Diagnosis Product and Solutions
2.3.4 Roche Diagnostics STDs Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Roche Diagnostics Recent Developments and Future Plans
2.4 Biomerieux
2.4.1 Biomerieux Details
2.4.2 Biomerieux Major Business
2.4.3 Biomerieux STDs Diagnosis Product and Solutions
2.4.4 Biomerieux STDs Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Biomerieux Recent Developments and Future Plans
2.5 Gen-Probe
2.5.1 Gen-Probe Details
2.5.2 Gen-Probe Major Business
2.5.3 Gen-Probe STDs Diagnosis Product and Solutions
2.5.4 Gen-Probe STDs Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Gen-Probe Recent Developments and Future Plans
2.6 Beckman Coulter
2.6.1 Beckman Coulter Details
2.6.2 Beckman Coulter Major Business
2.6.3 Beckman Coulter STDs Diagnosis Product and Solutions
2.6.4 Beckman Coulter STDs Diagnosis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Beckman Coulter Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global STDs Diagnosis Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 STDs Diagnosis Players Market Share in 2021
3.2.2 Top 10 STDs Diagnosis Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 STDs Diagnosis Players Head Office, Products and Services Provided
3.4 STDs Diagnosis Mergers & Acquisitions
3.5 STDs Diagnosis New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global STDs Diagnosis Revenue and Market Share by Type (2017-2022)
4.2 Global STDs Diagnosis Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global STDs Diagnosis Revenue Market Share by Application (2017-2022)
5.2 Global STDs Diagnosis Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America STDs Diagnosis Revenue by Type (2017-2028)
6.2 North America STDs Diagnosis Revenue by Application (2017-2028)
6.3 North America STDs Diagnosis Market Size by Country
6.3.1 North America STDs Diagnosis Revenue by Country (2017-2028)
6.3.2 United States STDs Diagnosis Market Size and Forecast (2017-2028)
6.3.3 Canada STDs Diagnosis Market Size and Forecast (2017-2028)
6.3.4 Mexico STDs Diagnosis Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe STDs Diagnosis Revenue by Type (2017-2028)
7.2 Europe STDs Diagnosis Revenue by Application (2017-2028)
7.3 Europe STDs Diagnosis Market Size by Country
7.3.1 Europe STDs Diagnosis Revenue by Country (2017-2028)
7.3.2 Germany STDs Diagnosis Market Size and Forecast (2017-2028)
7.3.3 France STDs Diagnosis Market Size and Forecast (2017-2028)
7.3.4 United Kingdom STDs Diagnosis Market Size and Forecast (2017-2028)
7.3.5 Russia STDs Diagnosis Market Size and Forecast (2017-2028)
7.3.6 Italy STDs Diagnosis Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific STDs Diagnosis Revenue by Type (2017-2028)
8.2 Asia-Pacific STDs Diagnosis Revenue by Application (2017-2028)
8.3 Asia-Pacific STDs Diagnosis Market Size by Region
8.3.1 Asia-Pacific STDs Diagnosis Revenue by Region (2017-2028)
8.3.2 China STDs Diagnosis Market Size and Forecast (2017-2028)
8.3.3 Japan STDs Diagnosis Market Size and Forecast (2017-2028)
8.3.4 South Korea STDs Diagnosis Market Size and Forecast (2017-2028)
8.3.5 India STDs Diagnosis Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia STDs Diagnosis Market Size and Forecast (2017-2028)
8.3.7 Australia STDs Diagnosis Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America STDs Diagnosis Revenue by Type (2017-2028)
9.2 South America STDs Diagnosis Revenue by Application (2017-2028)
9.3 South America STDs Diagnosis Market Size by Country
9.3.1 South America STDs Diagnosis Revenue by Country (2017-2028)
9.3.2 Brazil STDs Diagnosis Market Size and Forecast (2017-2028)
9.3.3 Argentina STDs Diagnosis Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa STDs Diagnosis Revenue by Type (2017-2028)
10.2 Middle East & Africa STDs Diagnosis Revenue by Application (2017-2028)
10.3 Middle East & Africa STDs Diagnosis Market Size by Country
10.3.1 Middle East & Africa STDs Diagnosis Revenue by Country (2017-2028)
10.3.2 Turkey STDs Diagnosis Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia STDs Diagnosis Market Size and Forecast (2017-2028)
10.3.4 UAE STDs Diagnosis Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global STDs Diagnosis Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global STDs Diagnosis Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market STDs Diagnosis Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global STDs Diagnosis Revenue (USD Million) by Region (2017-2022)
Table 5. Global STDs Diagnosis Revenue Market Share by Region (2023-2028)
Table 6. Becton Corporate Information, Head Office, and Major Competitors
Table 7. Becton Major Business
Table 8. Becton STDs Diagnosis Product and Solutions
Table 9. Becton STDs Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Dickinson Corporate Information, Head Office, and Major Competitors
Table 11. Dickinson Major Business
Table 12. Dickinson STDs Diagnosis Product and Solutions
Table 13. Dickinson STDs Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Roche Diagnostics Corporate Information, Head Office, and Major Competitors
Table 15. Roche Diagnostics Major Business
Table 16. Roche Diagnostics STDs Diagnosis Product and Solutions
Table 17. Roche Diagnostics STDs Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Biomerieux Corporate Information, Head Office, and Major Competitors
Table 19. Biomerieux Major Business
Table 20. Biomerieux STDs Diagnosis Product and Solutions
Table 21. Biomerieux STDs Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Gen-Probe Corporate Information, Head Office, and Major Competitors
Table 23. Gen-Probe Major Business
Table 24. Gen-Probe STDs Diagnosis Product and Solutions
Table 25. Gen-Probe STDs Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Beckman Coulter Corporate Information, Head Office, and Major Competitors
Table 27. Beckman Coulter Major Business
Table 28. Beckman Coulter STDs Diagnosis Product and Solutions
Table 29. Beckman Coulter STDs Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Global STDs Diagnosis Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 31. Global STDs Diagnosis Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 32. Breakdown of STDs Diagnosis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. STDs Diagnosis Players Head Office, Products and Services Provided
Table 34. STDs Diagnosis Mergers & Acquisitions in the Past Five Years
Table 35. STDs Diagnosis New Entrants and Expansion Plans
Table 36. Global STDs Diagnosis Revenue (USD Million) by Type (2017-2022)
Table 37. Global STDs Diagnosis Revenue Share by Type (2017-2022)
Table 38. Global STDs Diagnosis Revenue Forecast by Type (2023-2028)
Table 39. Global STDs Diagnosis Revenue by Application (2017-2022)
Table 40. Global STDs Diagnosis Revenue Forecast by Application (2023-2028)
Table 41. North America STDs Diagnosis Revenue by Type (2017-2022) & (USD Million)
Table 42. North America STDs Diagnosis Revenue by Type (2023-2028) & (USD Million)
Table 43. North America STDs Diagnosis Revenue by Application (2017-2022) & (USD Million)
Table 44. North America STDs Diagnosis Revenue by Application (2023-2028) & (USD Million)
Table 45. North America STDs Diagnosis Revenue by Country (2017-2022) & (USD Million)
Table 46. North America STDs Diagnosis Revenue by Country (2023-2028) & (USD Million)
Table 47. Europe STDs Diagnosis Revenue by Type (2017-2022) & (USD Million)
Table 48. Europe STDs Diagnosis Revenue by Type (2023-2028) & (USD Million)
Table 49. Europe STDs Diagnosis Revenue by Application (2017-2022) & (USD Million)
Table 50. Europe STDs Diagnosis Revenue by Application (2023-2028) & (USD Million)
Table 51. Europe STDs Diagnosis Revenue by Country (2017-2022) & (USD Million)
Table 52. Europe STDs Diagnosis Revenue by Country (2023-2028) & (USD Million)
Table 53. Asia-Pacific STDs Diagnosis Revenue by Type (2017-2022) & (USD Million)
Table 54. Asia-Pacific STDs Diagnosis Revenue by Type (2023-2028) & (USD Million)
Table 55. Asia-Pacific STDs Diagnosis Revenue by Application (2017-2022) & (USD Million)
Table 56. Asia-Pacific STDs Diagnosis Revenue by Application (2023-2028) & (USD Million)
Table 57. Asia-Pacific STDs Diagnosis Revenue by Region (2017-2022) & (USD Million)
Table 58. Asia-Pacific STDs Diagnosis Revenue by Region (2023-2028) & (USD Million)
Table 59. South America STDs Diagnosis Revenue by Type (2017-2022) & (USD Million)
Table 60. South America STDs Diagnosis Revenue by Type (2023-2028) & (USD Million)
Table 61. South America STDs Diagnosis Revenue by Application (2017-2022) & (USD Million)
Table 62. South America STDs Diagnosis Revenue by Application (2023-2028) & (USD Million)
Table 63. South America STDs Diagnosis Revenue by Country (2017-2022) & (USD Million)
Table 64. South America STDs Diagnosis Revenue by Country (2023-2028) & (USD Million)
Table 65. Middle East & Africa STDs Diagnosis Revenue by Type (2017-2022) & (USD Million)
Table 66. Middle East & Africa STDs Diagnosis Revenue by Type (2023-2028) & (USD Million)
Table 67. Middle East & Africa STDs Diagnosis Revenue by Application (2017-2022) & (USD Million)
Table 68. Middle East & Africa STDs Diagnosis Revenue by Application (2023-2028) & (USD Million)
Table 69. Middle East & Africa STDs Diagnosis Revenue by Country (2017-2022) & (USD Million)
Table 70. Middle East & Africa STDs Diagnosis Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. STDs Diagnosis Picture
Figure 2. Global STDs Diagnosis Revenue Market Share by Type in 2021
Figure 3. Gonorrhea Testing
Figure 4. Human Papilloma Virus (HPV) Testing
Figure 5. Chlamydia Testing
Figure 6. Chancroid Testing
Figure 7. Other
Figure 8. STDs Diagnosis Revenue Market Share by Application in 2021
Figure 9. Point-Of-Care (POC) Testing Picture
Figure 10. Laboratory Testing Picture
Figure 11. Global STDs Diagnosis Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global STDs Diagnosis Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global STDs Diagnosis Revenue Market Share by Region (2017-2028)
Figure 14. Global STDs Diagnosis Revenue Market Share by Region in 2021
Figure 15. North America STDs Diagnosis Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe STDs Diagnosis Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific STDs Diagnosis Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America STDs Diagnosis Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa STDs Diagnosis Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. STDs Diagnosis Market Drivers
Figure 21. STDs Diagnosis Market Restraints
Figure 22. STDs Diagnosis Market Trends
Figure 23. Becton Recent Developments and Future Plans
Figure 24. Dickinson Recent Developments and Future Plans
Figure 25. Roche Diagnostics Recent Developments and Future Plans
Figure 26. Biomerieux Recent Developments and Future Plans
Figure 27. Gen-Probe Recent Developments and Future Plans
Figure 28. Beckman Coulter Recent Developments and Future Plans
Figure 29. Global STDs Diagnosis Revenue Share by Players in 2021
Figure 30. STDs Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 31. Global Top 3 Players STDs Diagnosis Revenue Market Share in 2021
Figure 32. Global Top 10 Players STDs Diagnosis Revenue Market Share in 2021
Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 34. Global STDs Diagnosis Revenue Share by Type in 2021
Figure 35. Global STDs Diagnosis Market Share Forecast by Type (2023-2028)
Figure 36. Global STDs Diagnosis Revenue Share by Application in 2021
Figure 37. Global STDs Diagnosis Market Share Forecast by Application (2023-2028)
Figure 38. North America STDs Diagnosis Sales Market Share by Type (2017-2028)
Figure 39. North America STDs Diagnosis Sales Market Share by Application (2017-2028)
Figure 40. North America STDs Diagnosis Revenue Market Share by Country (2017-2028)
Figure 41. United States STDs Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada STDs Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico STDs Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe STDs Diagnosis Sales Market Share by Type (2017-2028)
Figure 45. Europe STDs Diagnosis Sales Market Share by Application (2017-2028)
Figure 46. Europe STDs Diagnosis Revenue Market Share by Country (2017-2028)
Figure 47. Germany STDs Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France STDs Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom STDs Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia STDs Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy STDs Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific STDs Diagnosis Sales Market Share by Type (2017-2028)
Figure 53. Asia-Pacific STDs Diagnosis Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific STDs Diagnosis Revenue Market Share by Region (2017-2028)
Figure 55. China STDs Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan STDs Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. South Korea STDs Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India STDs Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia STDs Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia STDs Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America STDs Diagnosis Sales Market Share by Type (2017-2028)
Figure 62. South America STDs Diagnosis Sales Market Share by Application (2017-2028)
Figure 63. South America STDs Diagnosis Revenue Market Share by Country (2017-2028)
Figure 64. Brazil STDs Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Argentina STDs Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Middle East and Africa STDs Diagnosis Sales Market Share by Type (2017-2028)
Figure 67. Middle East and Africa STDs Diagnosis Sales Market Share by Application (2017-2028)
Figure 68. Middle East and Africa STDs Diagnosis Revenue Market Share by Country (2017-2028)
Figure 69. Turkey STDs Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Saudi Arabia STDs Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. UAE STDs Diagnosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Methodology
Figure 73. Research Process and Data Source